The collaboration supports efforts for HIV prevention through PrEP, emphasizing Hetero’s commitment to improving HIV care.

It is one of six global partners to have signed a voluntary licence agreement with Gilead to produce a high-quality generic ...

The Israeli military issued evacuation warnings for 20 more towns and villages in southern Lebanon, signaling a potential ...

Surprise: Hannah and I switched Slog days. Because I respect tradition, we’ll begin with the weather, which is quite nice ...

Gilead Sciences is granting licenses to six companies to produce lenacapavir for pre-exposure prophylaxis, as well as for ...

Europe has announced a €2 million project to research long COVID, following €100 million already invested since 2021. Is all ...

The decision to allow generic versions of lenacapavir, which would go to countries with the highest rates of infection, has the potential to bring about an end to the HIV pandemic.

Gilead Sciences has announced the signing of voluntary licencing agreements with six generic pharmaceutical manufacturers to ...

A new licensing agreement from Gilead Sciences and six generic drug manufacturers is poised to transform HIV prevention ...

HIV expert Linda-Gail Bekker talks to The Conversation Weekly about promising results from a trial of a new drug for HIV ...

Gilead Sciences Inc. has entered into non-exclusive, royalty-free licensing agreements with six pharmaceutical manufacturers to produce and distribute generic versions of lenacapavir, a promising drug ...